ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

ATCO.A

164.55

+0.34%↑

SWED.A

253.9

+0.28%↑

SCA.A

128.45

+0.67%↑

SHB.B

199.7

+1.27%↑

LATOB

266.6

-0.41%↓

Search

Biotage AB

Fermé

141.9 0.35

Résumé

Variation du prix de l'action

24h

Actuel

Min

141.4

Max

142.1

Chiffres clés

By Trading Economics

Revenu

-154M

4M

Ventes

-197M

385M

P/E

Moyenne du Secteur

44.606

24.598

BPA

0.325

Rendement du dividende

1.16

Marge bénéficiaire

1.039

Employés

622

EBITDA

-194M

28M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.16%

4.30%

Prochains Résultats

16 juil. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.1B

11B

Ouverture précédente

141.55

Clôture précédente

141.9

Biotage AB Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 avr. 2025, 06:50 UTC

Acquisitions, Fusions, Rachats

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 avr. 2025, 06:04 UTC

Acquisitions, Fusions, Rachats

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 avr. 2025, 06:03 UTC

Acquisitions, Fusions, Rachats

KKR: Biotage Board Recommends Shareholders Accept Offer

22 avr. 2025, 06:02 UTC

Acquisitions, Fusions, Rachats

KKR: Offer Values Biotage at SEK11.61B

22 avr. 2025, 06:02 UTC

Acquisitions, Fusions, Rachats

KKR Makes SEK145 a Share Bid For Biotage

Comparaison

Variation de prix

Biotage AB prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.